These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6120704)

  • 1. Evaluation of efficacy and safety of midazolam administered orally in sleep disorders. A dose-finding study.
    Lupolover R; Buch JP
    Arzneimittelforschung; 1981; 31(12a):2281-3. PubMed ID: 6120704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy and tolerance of orally administered midazolam as hypnotic agent compared with oxazepam in the treatment of insomnia of mild to moderate severity.
    Helcl I; Lupolover R; Buch JP; Amrein R
    Arzneimittelforschung; 1981; 31(12a):2284-7. PubMed ID: 6120705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term sleep laboratory evaluation of midazolam in chronic insomniacs. Preliminary results.
    Monti JM; Alterwain P; Debellis J; Altier H; Pellejero T; Monti D
    Arzneimittelforschung; 1987 Jan; 37(1):54-7. PubMed ID: 3551970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults.
    Schenck CH; Mahowald MW
    Am J Med; 1996 Mar; 100(3):333-7. PubMed ID: 8629680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of benzodiazepine use in individuals with insomnia.
    Morin CM; Bélanger L; Bernier F
    Sleep Med; 2004 Sep; 5(5):457-62. PubMed ID: 15341890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.
    Tietz EI; Roth T; Zorick FJ; Piccione P; Kramer M
    Arzneimittelforschung; 1981; 31(11):1963-6. PubMed ID: 6119098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose.
    Borbély AA; Loepfe M; Mattmann P; Tobler I
    Arzneimittelforschung; 1983; 33(10):1500-2. PubMed ID: 6140018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of midazolam and oxazepam in insomniacs.
    Lupolover R; Ballmer U; Helcl J; Escher J; Pavletic B
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):139S-143S. PubMed ID: 6138067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intramuscular application of midazolam. Its effect upon CNS and respiration (author's transl)].
    Grote B; Doenicke A; Kugler J; Suttmann H; Loos A
    Arzneimittelforschung; 1981; 31(12a):2224-5. PubMed ID: 6120701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term quazepam treatment of insomnia in geriatric patients.
    Caldwell JR
    Pharmatherapeutica; 1982; 3(4):278-82. PubMed ID: 6128741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of oral midazolam as a hypnotic compared with lorazepam.
    Lorizio A; Salsa F
    Pharmatherapeutica; 1986; 4(7):463-71. PubMed ID: 2938195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
    Mendels J
    J Clin Psychiatry; 1994 Feb; 55(2):60-5. PubMed ID: 7915708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues in the use of benzodiazepine therapy.
    Roth T; Roehrs TA
    J Clin Psychiatry; 1992 Jun; 53 Suppl():14-8. PubMed ID: 1613014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of flunitrazepam in a hospital department of psychiatry].
    Brunner H; Patris MF; Baudry P; Feugère T; Wertenschlag H
    Nouv Presse Med; 1979 Jul; 8(31):2541-3. PubMed ID: 40192
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of midazolam on sleep in normal subjects.
    Krieger J; Mangin P; Kurtz D
    Arzneimittelforschung; 1983; 33(7):1000-2. PubMed ID: 6138044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between clinical effects and pharmacokinetics of midazolam on i.m. and i.v. application to volunteers/1st comm.: Clinical aspects (author's transl)].
    Ziegler WH; Thurneysen JD; Crevoisier C; Eckert M; Amrein R; Dubuis R
    Arzneimittelforschung; 1981; 31(12a):2206-10. PubMed ID: 6120699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
    Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midazolam: dose-response studies of effectiveness and rebound insomnia.
    Kales A; Soldatos CR; Bixler EO; Goff PJ; Vela-Bueno A
    Pharmacology; 1983; 26(3):138-49. PubMed ID: 6132414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
    Mauri MC; Gianetti S; Pugnetti L; Altamura AC
    Int J Clin Pharmacol Res; 1993; 13(3):173-7. PubMed ID: 7901174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of insomnia and benzodiazepines].
    Gmitrowicz A
    Przegl Lek; 1988; 45(10):739-42. PubMed ID: 2907664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.